Account
Inquiry
QSC Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for type 2 diabetes treatment. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The mechanism of action involves mimicking natural GIP at the GIP receptor while simultaneously activating GLP-1 receptors. This dual activity produces enhanced reductions in hyperglycemia and promotes weight loss through appetite suppression and slowed gastric emptying.
Our QSC Tirzepatide is supplied as a white powder with purity exceeding 98%, rigorously tested by HPLC. The product is stable when stored properly and maintains activity for extended periods under recommended storage conditions.
As a research chemical, QSC Tirzepatide is intended for laboratory use only by qualified professionals. This product is not for human consumption and should be handled with appropriate safety precautions.
